BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Earable Neuroscience and Excelpoint Partner to Commercialize AI-Powered FRENZ Brainband for Global Sleep Pandemic

Since the COVID-19 pandemic began, researchers around the world have documented a surge in sleep disorders which affect overall health, safety and qualit...

March 31, 2023 | News

Verbal Beginnings Partners with The Clinician for Autism Patient Reported Outcomes Program

The program will enable Verbal Beginnings' clients, families, and caregivers to remotely report on the health outcomes that matter most to them, including ...

March 29, 2023 | News

Aurion Biotech Receives Approval from Japan’s PMDA for New Drug Application

Aurion Biotech, whose mission is to restore vision to millions of patients with its life-changing regenerative therapies, today announced it has received r...

March 27, 2023 | News

Autism Speaks Pledges to Make World of Difference as Autism Prevalence Rises to 2.7% of Children in U.S.

The Centers for Disease Control and Prevention (CDC) released today its update of autism's estimated prevalence among the nation's children, based on the a...

March 24, 2023 | News

Roche announces collaboration with Lilly to enhance early diagnosis of Alzheimer's disease

Roche and Lilly will collaborate on the development of Roche Diagnostics’ Elecsys Amyloid Plasma Panel The Elecsys Amyloid Pla...

March 24, 2023 | News

Aitia and UCB Announce Strategic Drug Discovery Collaboration in Huntington's Disease

Huntington's disease is a debilitating genetic disorder that affects the brain, causing gradual degeneration of nerve cells in specific areas of the brain,...

March 20, 2023 | News

Hopper Health Launches Personalized Primary Care For Neurodivergent Adults

One in five adults experiences neurodivergent conditions like Autism, ADHD, Tourette's, and OCD, and is more likely to avoid care due to previous negativ...

March 17, 2023 | News

"Anura™ contactless health monitoring tech to integrate with mobile devices

Monitor blood pressure and predict a person's risk of pre-diabetes in just 30 seconds using only a smartphone video camera NuraLogix, a global pioneer of ...

February 27, 2023 | News

Inventia Life Science collaborates with MSD to develop 3D advanced cell models

Collaboration to develop 3D in vitro models of the brain for the discovery of therapeutic candidates using Inventia's novel 3D cell culture platform, RASTR...

February 16, 2023 | News

Sentia Medical Sciences and Neurocrine Biosciences Extend Research Collaboration to Discover Novel CRF Peptides

The collaboration will continue to leverage Sentia’s proprietary peptide-based platform and Neurocrine’s drug development expertise in CR...

February 15, 2023 | News

STADA builds on Movapo heritage to offer Australian Parkinson’s patients new option

Can you explain the details of the new medicine now available on the Pharmaceutical Benefits Scheme for people with Parkinson's disease? Ongentys (opicapo...

February 13, 2023 | News

New Parkinson's Disease treatment added to PBS

Opicapone will be listed for the first time as additional therapy to treat Parkinson’s disease, helping other medications work better and for ...

February 02, 2023 | News

Eppendorf & Science Prize for Neurobiology 2023 Call for Entries!

This annual international research prize of US$25,000 is awarded to young scientists for their outstanding contributions to neurobiological research based ...

February 02, 2023 | News

AffaMed Therapeutics to commercialize Galcanezumab for Migraine Prevention in Mainland China

AffaMed Therapeutics ("AffaMed"), a global clinical stage biopharmaceutical company dedicated to address critical unmet medical needs in neurological, psyc...

January 17, 2023 | News

Stay Connected